).
Regulation of Cellular Fatty Acid Uptake:
It has long been known that adipocytes from obese subjects, whether rodent or human, are larger than those from the non-obese. We have furthermore reported in rodents that up-regulation of adipocyte LCFA uptake precedes increased adipocyte size and weight gain, and that during leptin therapy in ob/ob mice, downregulation of adipocyte LCFA uptake and decreased adipocyte size precede weight loss.
The present study, in human adipose tissue, supports the idea that regulation of LCFA uptake in adipocytes is an important part of the regulation of both adipocyte size & body weight in man. Measures of BMI, % Body Fat, & adipocyte size were significantly correlated with LCFA uptake, as quantified by the uptake Vmax (Supplemental Figure 1) . weight, if the proportional change in adipocyte surface area is similar to the proportional change in Vmax, Vmax' will be nearly unchanged from its initial, pre-weight loss or weight gain value. However, if there were major differences in the proportional changes in Vmax and SA: e.g. if adipocytes after weight loss were especially small, as is seen not infrequently during active, ongoing weight loss, calculated Vmax' would be increased, despite a decrease in both Vmax and SA. Although, on average, both Vmax and SA decreased following the initial sleeve gastrectomy in the SO/SOr patients reported in this paper, Vmax' tended most often to increase, due to a larger proportional decrease in adipocyte surface area. Manuscript Figure 7 illustrates the pattern observed during weight loss in this study. Supplemental Table 3 These data demonstrate a significant but not surprising linear correlation between BMI and % Body Fat. dimensions, Vmax' decreased in patient #1 but increased in patient 2 because of a greater reduction in adipocyte size in the latter.
What are the pathophysiologic implications of this increase in Vmax'? Vmax' seems to provide some sort of basis for classifying adipocytes on the basis of their capacity to take up LCFA, but more needs to be learned about ts implications. We do not yet know precisely what constitutes the LCFA "transport machinery" in adipocyte plasma membranes, but assume that at least some of it consists of membrane proteins with an LCFA binding/transport capability. The rest of the plasma membrane is comprised of other proteins & membrane lipids. As adipocytes shrink with weight loss, the area of plasma membranes also shrinks, presumably with a loss of both membrane proteins and lipids. The increase in Vmax' implies that more functional "transport machinery", i.e. specific membrane proteins with preserved LCFA binding/ transport capabilities, has crowded into a smaller available space in/on the plasma membrane. Although we have no data yet that supports this hypothesis, we assume that, to accommodate the preservation of LCFA transportrelated proteins despite the loss of cell surface area, other membrane proteins will be lost from the cell either by shedding or degradation. Thus, the residual plasma membrane proteins of SOr adipocytes are likely to represent a protein preparation enriched in "transport machinery" proteins.
What determines the size of an adipocyte is also not clear. Is the cell membrane simply an elastic receptacle which enlarges or shrinks as necessary to accommodate intracellular organelles, including lipid droplets, within? Or are there other, adipocyte specific, regulatory processes that determine the sizes of these cells, and are these processes in some way a part of the body's responses to obesity? We have not learned the answer to these questions during the current studies. What we have learned is the value of getting to know your neighborhood bariatric surgeon. Among their many virtues, they can be a source of large quantities of viable human adipose tissue, which can be the basis for important, productive studies.
